CK19, CK20, EGFR and HER2 status of circulating tumor cells in patients with breast cancer.

@article{Tunca2012CK19CE,
  title={CK19, CK20, EGFR and HER2 status of circulating tumor cells in patients with breast cancer.},
  author={Berrin Tunca and Unal Egeli and Gulsah Cecener and Gulçin Tezcan and Sehsuvar G{\"o}kg{\"o}z and Ismet Taşdelen and Nuran Bayram and Şahsine Tolunay and Gorkem Umut and Elif Demirdogen and Elif Erturk and Seçil Ak and Sibel Kahraman Çetintaş and Turkkan Evrensel},
  journal={Tumori},
  year={2012},
  volume={98 2},
  pages={243-51}
}
AIMS AND BACKGROUND The major cause of death in breast cancer patients is metastasis. Various biomarkers have been used for the early detection of circulating tumor cells in the peripheral blood of breast cancer patients. The aims of the current study were to analyze circulating tumor cells in the blood of breast cancer patients by investigating EGFR, CK19, CK20 and HER2 expression profiles and to evaluate their prognostic importance. METHODS CK19, CK20 and EGFR gene expression profiles were… CONTINUE READING